S. Aureus Diagnosis: Comprehensive Guide for Clinicians

Introduction

Staphylococcus aureus (S. aureus) is a significant bacterial pathogen renowned for its diverse clinical manifestations, ranging from superficial skin infections to life-threatening systemic diseases. Accurate and timely diagnosis of S. aureus infections is paramount for effective clinical management, guiding appropriate antibiotic therapy and infection control measures, especially considering the rise of antibiotic-resistant strains like Methicillin-resistant Staphylococcus aureus (MRSA). This article provides an in-depth guide to S. aureus diagnosis, essential for healthcare professionals in the English-speaking world.

Clinical Suspicion and Initial Assessment

The diagnostic process for S. aureus begins with clinical suspicion based on the patient’s presentation and risk factors. S. aureus should be considered in a wide array of infections, including:

• Skin and Soft Tissue Infections (SSTIs): Boils, carbuncles, impetigo, cellulitis, and wound infections, particularly purulent lesions.
• Deep-seated Infections: Osteomyelitis, septic arthritis, endocarditis, pneumonia, and abscesses in various organs.
• Healthcare-Associated Infections (HAIs): Surgical site infections, catheter-related bloodstream infections, and infections associated with implanted medical devices.
• Food Poisoning: Suspect S. aureus enterotoxin-mediated food poisoning in cases of rapid-onset vomiting and diarrhea after consuming potentially contaminated food.
• Toxic Shock Syndrome (TSS): Consider TSS in patients presenting with fever, rash, hypotension, and multi-organ involvement, especially in menstruating women or following S. aureus infections.

A thorough patient history and physical examination are crucial initial steps. Information regarding the onset, location, and nature of symptoms, potential portals of entry, and risk factors for S. aureus infection (e.g., hospitalization, intravenous drug use, presence of indwelling devices) should be collected.

Laboratory Diagnosis of S. Aureus

Definitive diagnosis of S. aureus infection relies on laboratory confirmation. Various microbiological tests are employed to identify S. aureus from clinical specimens.

Specimen Collection

The type of specimen collected depends on the suspected site of infection:

• Skin and Wound Infections: Swabs of pus or wound exudate, tissue biopsies.
• Bloodstream Infections: Blood cultures (multiple sets, drawn from different sites).
• Respiratory Infections: Sputum, tracheal aspirates, bronchoalveolar lavage.
• Bone and Joint Infections: Bone or joint fluid aspirates, tissue biopsies.
• Urinary Tract Infections: Urine samples (clean-catch midstream urine).
• Food Poisoning: Food samples (if available), vomitus, or stool (less common for direct bacterial detection, but can be used to rule out other pathogens).
• Device-Related Infections: Removed devices (e.g., catheters, prosthetic joints) for sonication and culture.

Proper specimen collection techniques are critical to avoid contamination and ensure accurate results. Specimens should be transported to the laboratory promptly for processing.

Direct Microscopy: Gram Stain

Gram staining is a rapid initial step in bacterial identification. S. aureus appears as Gram-positive cocci, typically arranged in clusters resembling “bunches of grapes.” While Gram stain can provide presumptive evidence of staphylococcal infection, it cannot differentiate S. aureus from other staphylococcal species or definitively diagnose S. aureus. It is most useful for guiding initial antibiotic choices pending culture results.

Culture and Isolation

Bacterial culture is the gold standard for S. aureus diagnosis. Specimens are inoculated onto various agar media, including:

• Non-selective media: Blood agar, tryptic soy agar, and heart infusion agar support the growth of a wide range of bacteria, including S. aureus. S. aureus colonies on blood agar often exhibit beta-hemolysis, characterized by a clear zone of red blood cell lysis surrounding the colonies.
• Selective media: Mannitol salt agar (MSA) is selective for staphylococci due to its high salt concentration. S. aureus ferments mannitol, producing acid, which changes the pH indicator in the agar, resulting in yellow colonies with yellow zones. MSA aids in isolating staphylococci from mixed cultures.

Incubation is typically performed at 35-37°C in aerobic conditions. Colonies are examined after 18-24 hours of incubation.

Identification Tests

Once colonies are isolated, several biochemical and phenotypic tests are used to definitively identify S. aureus:

Catalase Test

The catalase test differentiates staphylococci (catalase-positive) from streptococci (catalase-negative). S. aureus produces catalase, an enzyme that breaks down hydrogen peroxide into water and oxygen. A positive catalase test is indicated by the immediate bubbling when a drop of 3% hydrogen peroxide is applied to a colony.

Coagulase Test

The coagulase test is a crucial test for differentiating S. aureus from coagulase-negative staphylococci (CoNS). S. aureus produces coagulase, an enzyme that clots blood plasma. Two forms of the coagulase test are used:

• Tube Coagulase Test: A tube containing rabbit plasma is inoculated with S. aureus. A positive test, indicated by clot formation after incubation, is highly specific for S. aureus.
• Slide Coagulase Test (Clumping Factor Test): This test detects cell-bound coagulase (clumping factor). A drop of rabbit plasma is mixed with a colony on a slide. Clumping of bacterial cells within seconds indicates a positive test. However, the slide coagulase test is less reliable than the tube coagulase test and should be confirmed with the tube test.

While traditionally considered the hallmark of S. aureus, it’s important to note that some rare S. aureus strains may be coagulase-negative. Conversely, Staphylococcus lugdunensis, a CoNS species, can be coagulase-positive. Therefore, coagulase testing should be interpreted in conjunction with other tests.

Thermostable Deoxyribonuclease (DNase) Test

S. aureus produces a thermostable DNase. This test detects the ability of an organism to hydrolyze DNA. A positive DNase test is indicated by a clear zone around bacterial growth on a DNase test agar plate after flooding with hydrochloric acid. The thermostable DNase test is a highly reliable test for S. aureus identification, particularly useful in differentiating S. aureus from coagulase-negative staphylococci and coagulase-variable strains.

Latex Agglutination Tests

Commercial latex agglutination tests provide rapid identification of S. aureus. These tests utilize latex particles coated with antibodies against S. aureus antigens, such as clumping factor and protein A. Agglutination (clumping) of latex particles when mixed with S. aureus colonies indicates a positive result. Some newer tests also include antibodies to capsular polysaccharides to improve sensitivity and reduce false negatives. While rapid and convenient, positive latex agglutination tests should ideally be confirmed by traditional methods, especially in cases with discordant clinical findings.

Biochemical and Automated Identification Systems

For comprehensive identification of staphylococcal species, including CoNS, automated or semi-automated biochemical identification systems are frequently used. These systems, such as API Staph, Vitek, and MicroScan, utilize panels of biochemical tests to generate a biochemical profile of the isolate. The profile is then compared to databases to identify the bacterial species. These systems are particularly valuable for identifying CoNS, which are increasingly recognized as significant pathogens, especially in device-related infections.

Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing (AST) is crucial for guiding antibiotic therapy for S. aureus infections. S. aureus is notorious for its ability to develop resistance to various antibiotics. AST determines the susceptibility or resistance of S. aureus isolates to a panel of antimicrobial agents. Common methods include:

• Disk Diffusion (Kirby-Bauer) Method: Antibiotic-impregnated disks are placed on agar plates inoculated with S. aureus. After incubation, the diameters of the zones of inhibition around the disks are measured and interpreted as susceptible, intermediate, or resistant based on standardized guidelines (e.g., CLSI).
• Broth Microdilution or Agar Dilution: These methods determine the minimum inhibitory concentration (MIC), the lowest concentration of an antibiotic that inhibits bacterial growth. MIC values are used to categorize isolates as susceptible, intermediate, or resistant.
• Automated AST Systems: Automated systems streamline AST and provide rapid results. They often utilize microdilution principles and can simultaneously perform identification and susceptibility testing.

Detection of Methicillin Resistance (MRSA):

Methicillin resistance in S. aureus is mediated by the mecA gene, which encodes for an altered penicillin-binding protein (PBP2a) with reduced affinity for beta-lactam antibiotics. Detection of MRSA is critical due to its implications for treatment and infection control. Methods for MRSA detection include:

• Cefoxitin Disk Diffusion: Cefoxitin is a reliable indicator for mecA-mediated resistance. Reduced zone diameters around cefoxitin disks indicate likely methicillin resistance.
• Oxacillin Screen Agar: This agar contains a high concentration of oxacillin and 6% NaCl. MRSA strains can grow on this medium, while methicillin-susceptible S. aureus (MSSA) strains are inhibited.
• Latex Agglutination Tests for PBP2a: These rapid tests directly detect the PBP2a protein.
• PCR for mecA gene: Molecular tests, such as polymerase chain reaction (PCR), directly detect the mecA gene, providing highly sensitive and specific MRSA detection. PCR is particularly useful for rapid detection and confirmation of MRSA, especially in screening programs.

Molecular Diagnostic Methods

Molecular methods are increasingly used in S. aureus diagnosis, particularly for rapid detection, strain typing, and detection of virulence factors and resistance genes.

• Real-time PCR: Real-time PCR assays can rapidly detect S. aureus DNA directly from clinical specimens, providing faster results than traditional culture methods. Multiplex PCR assays can simultaneously detect S. aureus and the mecA gene for rapid MRSA detection.
• Nucleic Acid Amplification Tests (NAATs): Various commercial NAATs are available for rapid detection of S. aureus and MRSA from nasal swabs, wound specimens, and blood cultures. These tests are valuable for rapid screening and diagnosis, especially in settings requiring prompt results, such as surgical site infection surveillance or bloodstream infection diagnosis.
• Strain Typing Methods: Molecular typing methods, such as pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and spa typing, are used for epidemiological investigations, outbreak detection, and tracking the spread of S. aureus strains, including MRSA. These methods help determine the relatedness of isolates and understand transmission patterns.

Figure 1. Pathogenesis of Staphylococcal Infections: This image illustrates the various stages and mechanisms involved in the pathogenesis of staphylococcal infections, highlighting the complexity of S. aureus virulence.

Diagnosis of S. Aureus Food Poisoning

Diagnosis of S. aureus food poisoning is primarily clinical, based on the characteristic symptoms and rapid onset after consuming suspect food. Laboratory confirmation is often not routinely performed but can be pursued in outbreak investigations or severe cases. Methods include:

• Enterotoxin Detection: Stool, vomitus, or food samples can be tested for the presence of S. aureus enterotoxins using enzyme immunoassays (EIAs) or latex agglutination assays.
• Culture of Food Samples: Food samples can be cultured to isolate S. aureus. However, the presence of S. aureus in food does not definitively confirm food poisoning, as enterotoxin production needs to be demonstrated.

Diagnosis of Toxic Shock Syndrome (TSS)

Diagnosis of TSS is based on clinical criteria, as defined by the Centers for Disease Control and Prevention (CDC). Laboratory tests support the diagnosis and rule out other conditions. Relevant laboratory findings include:

• Isolation of S. aureus: Culture from the infection site (if present) is often positive for S. aureus.
• Elevated inflammatory markers: Elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR).
• Organ dysfunction markers: Elevated creatinine, liver enzymes, thrombocytopenia.
• Toxin detection (research settings): In specialized laboratories, assays to detect TSST-1 or staphylococcal enterotoxins in serum may be performed, but these are not routinely available for clinical diagnosis.

Differential Diagnosis

It is crucial to differentiate S. aureus infections from other conditions that may present with similar symptoms. Differential diagnoses vary depending on the clinical presentation but may include:

• Other bacterial infections: Streptococcal infections (e.g., cellulitis, impetigo), other Gram-positive cocci, Gram-negative bacterial infections.
• Viral infections: Herpes simplex virus (impetigo-like lesions), viral gastroenteritis (food poisoning).
• Fungal infections: Cutaneous fungal infections (skin lesions).
• Non-infectious conditions: Contact dermatitis, allergic reactions, autoimmune diseases.

Laboratory testing plays a crucial role in differentiating S. aureus infections from these conditions.

Conclusion

Accurate and timely diagnosis of S. aureus infections is essential for effective patient care and infection control. Diagnosis relies on a combination of clinical suspicion, appropriate specimen collection, and a range of laboratory tests, including Gram stain, culture, biochemical identification, antimicrobial susceptibility testing, and increasingly, molecular diagnostic methods. Understanding the principles and applications of these diagnostic approaches is critical for clinicians in managing the diverse spectrum of S. aureus infections and combating the challenge of antibiotic resistance. Continuous advancements in diagnostic technologies are further refining our ability to rapidly and accurately diagnose S. aureus infections, leading to improved patient outcomes and public health.

References

1. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55:733. [PMC free article: PMC372845] [PubMed: 1779933]
2. Easmon CSF, Adlam C: Staphylococci and staphylococcal infections. Vols 1 and 2. Academic Press, London, 1983 .
3. Foster TJ. Potential for vaccination against infections caused by Staphylococcus aureus. Vaccine. 1991;9:221. [PubMed: 2058264]
4. Foster TJ, McDevitt D: Molecular basis of adherence of staphylococci to biomaterials. p. 31, In Bisno AL, Waldvogel FA (eds): Infections Associated with Indwelling Medical Devices, 2nd Edition. American Society for Microbiology, Washington, D.C., 1994.
5. Lyon BR, Skurray R. Antimicrobial resistance in Staphylococcus aureus: genetic basis. Microbiol Reviews. 1987;51:88. [PMC free article: PMC373094] [PubMed: 3031442]
6. Prevost G, Couppie P, Prevost P. et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol. 1995;42:237. [PubMed: 7707330]
7. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis. 1994;19:231. [PubMed: 7986894]
8. Schlievert PM. Role of superantigens in human disease. J Infect Dis. 1993;167:997. [PubMed: 8486972]
9. Skinner GRB, Ahmad, A: Staphylococcal vaccines – present status and future prospects. p. 537. In Mollby R, Flock JI, Nord CE, Christensson B (eds): Staphylococci and Staphylococcal Infections. Zbl. Bakt. Suppl. 26, Fischer Verlag, Stuttgart, 1994 .
10. Tenover F, Arbeit R, Archer G. et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol. 1994;32:407. [PMC free article: PMC263045] [PubMed: 7908673]
11. Vaudaux PE, Lew DP, Waldvogel FA: Host factors predisposing to and influencing therapy of foreign body infections. p. 1. In Bisno AL, Waldvogel FA (eds): Infections Associated with Indwelling Medical Devices. 2nd Ed. American Society for Microbiology, Washington, D.C., 1994 .